These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation. Ortblad KF, Mogere P, Roche S, Kamolloh K, Odoyo J, Irungu E, Mugo NR, Pintye J, Baeten JM, Bukusi E, Ngure K, Stakeholders for Pharmacy-based PrEP Delivery in Kenya Consultation. BMC Health Serv Res; 2020 Nov 12; 20(1):1034. PubMed ID: 33176785 [Abstract] [Full Text] [Related]
9. Design and evaluation of strategies to implement HIV prevention interventions for pregnant women in community pharmacy settings in western Kenya: a mixed-methods study protocol. Mugambi ML, Baeten JM, Kinuthia J, Hauber B, Weiner BJ, John-Stewart G, Barnabas RV. BMJ Open; 2021 Dec 15; 11(12):e052311. PubMed ID: 34911715 [Abstract] [Full Text] [Related]
13. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa. Little KM, Hanif H, Anderson SM, Clark MR, Gustafson K, Doncel GF. AIDS Behav; 2024 Mar 15; 28(3):936-950. PubMed ID: 37971614 [Abstract] [Full Text] [Related]
14. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment. Mugambi ML, Odhiambo BO, Dollah A, Marwa MM, Nyakina J, Kinuthia J, Baeten JM, Weiner BJ, John-Stewart G, Barnabas RV, Hauber B. J Int AIDS Soc; 2024 Jul 15; 27 Suppl 1(Suppl 1):e26301. PubMed ID: 38965978 [Abstract] [Full Text] [Related]
15. Harnessing private sector strategies for family planning to deliver the Dual Prevention Pill, the first multipurpose prevention technology with pre-exposure prophylaxis, in an expanding HIV prevention landscape. Verde Hashim C, Llewellyn E, Wood R, Brett T, Chinyanga T, Webb K, Segal K. J Int AIDS Soc; 2024 Aug 15; 27(8):e26346. PubMed ID: 39148275 [Abstract] [Full Text] [Related]
16. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa. Dietrich JJ, Atujuna M, Tshabalala G, Hornschuh S, Mulaudzi M, Koh M, Ahmed N, Muhumuza R, Ssemata AS, Otwombe K, Bekker LG, Seeley J, Martinson NA, Terris-Prestholt F, Fox J. BMC Health Serv Res; 2021 Jan 06; 21(1):17. PubMed ID: 33407395 [Abstract] [Full Text] [Related]
18. Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study. Ortblad KF, Kwach B, Zhang S, Asewe M, Ongwen PA, Malen RC, Harkey K, Odoyo J, Gathii P, Rota G, Sharma M, Were DK, Ngure K, Omollo V, Bukusi EA. J Int AIDS Soc; 2023 Oct 06; 26(10):e26177. PubMed ID: 37848405 [Abstract] [Full Text] [Related]